Physiologically based pharmacokinetic (PBPK) modeling: It is here to stay!

被引：22

作者：

Rostami-Hodjegan, Amin ^{[1
]}

Tamai, Ikumi ^{[2
]}

Pang, K. Sandy ^{[3
]}

机构：

[1] Univ Manchester, Manchester M13 9PL, Lancs, England

[2] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan

[3] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A1, Canada

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 2012年 / 33卷 / 02期

关键词：

D O I：

10.1002/bdd.1776

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：47 / 50

页数：4

共 9 条

[1] Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs? [J].

Bouzom, Francois ;

Ball, Kathryn ;

Perdaems, Nathalie ;

Walther, Bernard .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (02) :55-71

[2] Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies [J].

Chen, Yuan ;

Jin, Jin Y. ;

Mukadam, Sophie ;

Malhi, Vikram ;

Kenny, Jane R. .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (02) :85-98

[3] Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice [J].

Grillo, Joseph A. ;

Zhao, Ping ;

Bullock, Julie ;

Booth, Brian P. ;

Lu, Min ;

Robie-Suh, Kathy ;

Berglund, Eva Gil ;

Pang, K. Sandy ;

Rahman, Atiqur ;

Zhang, Lei ;

Lesko, Lawrence J. ;

Huang, Shiew-Mei .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (02) :99-110

[4] The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review [J].

Huang, S-M ;

Rowland, M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) :542-549

[5] Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice [J].

Johnson, Trevor N. ;

Rostami-Hodjegan, Amin .

PEDIATRIC ANESTHESIA, 2011, 21 (03) :291-301

[6] Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science [J].

Rowland, Malcolm ;

Peck, Carl ;

Tucker, Geoffrey .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011, 2011, 51 :45-73

[7] Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events [J].

Shaffer, Christopher L. ;

Scialis, Renato J. ;

Rong, Haojing ;

Obach, R. Scott .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (02) :72-84

[8] From preclinical to human - prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example [J].

Sinha, Vikash Kumar ;

Snoeys, Jan ;

Van Osselaer, Nancy ;

Van Peer, Achiel ;

Mackie, Claire ;

Heald, Donald .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (02) :111-121

[9] Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review [J].

Zhao, P. ;

Zhang, L. ;

Grillo, J. A. ;

Liu, Q. ;

Bullock, J. M. ;

Moon, Y. J. ;

Song, P. ;

Brar, S. S. ;

Madabushi, R. ;

Wu, T. C. ;

Booth, B. P. ;

Rahman, N. A. ;

Reynolds, K. S. ;

Berglund, E. Gil ;

Lesko, L. J. ;

Huang, S-M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) :259-267

← 1 →